Answers are grounded in this paper and cite their sources.
Shows that macrophage activation syndrome often coincides with pediatric lupus onset and raises mortality risk, highlighting the need for prompt corticosteroid treatment.
MAS was most likely to develop concomitantly with childhood-onset SLE diagnosis. The majority of the MAS patients were successfully treated with corticosteroids with no MAS relapses. Although the numbers were small, there was a higher risk of death associated with MAS compared to SLE without MAS.
No takes yet. Share an insight, caveat, or question.
Borgia et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: